Business
Branded Legacy Inc. Unveils Cutting-Edge GMP Facility to Accelerate Life-Saving Inhaled Naloxone Development
Branded Legacy Inc. Unveils Cutting-Edge GMP Facility to Accelerate Life-Saving Inhaled Naloxone Development.
About this update from Branded Legacy Inc.
[{"type":"text","content":"\r\n\r\n \r\n \r\n Branded Legacy Inc. Unveils Cutting-Edge GMP Facility to Accelerate Life-Saving Inhaled Naloxone Development\r\n \r\n \r\n\r\n\r\nBranded Legacy Inc. Unveils Cutting-Edge GMP Facility to Accelerate Life-Saving Inhaled Naloxone Development\r\nBioLegacy's New Vancouver Hub Drives Innovation in Opioid Crisis Solutions with Unmatched Manufacturing and Research Capabilities\r\n\r\n\r\n\r\n\r\n\r\nVANCOUVER, British Columbia, Sept. 23, 2025 (GLOBE NEWSWIRE) -- via IBN – BioLegacy Evaluative Group, Inc., a wholly-owned subsidiary of Branded Legacy Inc. (OTC: BLEG) and an emerging leader in life sciences innovation, proudly announces the official opening of its state-of-the-art 22,000-square-foot Good Manufacturing Practice (GMP) facility in Vancouver, Canada. This milestone, following the recent acquisition of the facility, establishes BLEG as a leader in developing innovative, low-cost inhaled naloxone devices to combat the escalating opioid overdose crisis. The new facility serves as BioLegacy's central hub for research, development, and production, building on Branded Legacy's strategic acquisition of BioLegacy Evaluative Group and partnerships with McMaster University and Stanford University's Dr. Eran Bendavid. These collaborations, combined with the facility's advanced infrastructure, enable BLEG to accelerate the development of safe, effective, and accessible overdose-reversal solutions. \"Our new facility is the foundation for BioLegacy's mission to deliver affordable, accessible overdose-reversal solutions at scale,\" said CEO Amin Janmohamed. \"By combining academic partnerships with state-of-the-art infrastructure, we are uniquely positioned to translate scientific breakthroughs into life-saving products.\" Facility Highlights \r\n State-of-the-Art GMP Facility – Built to global pharmaceutical standards, ensuring scalability and long-term value.\r\n Advanced ISO Class 7 & 8 Cleanrooms – Engineered for superior, compliant production across diverse product lines, maintaining strict particle limits (=352,000 particles/m³ =0.5 µm, =83,200 =1 µm, and =2,930 =5 µm in ISO 7 spaces) to ensure exceptional quality.\r\n High-Containment Capabilities: Equipped to safely handle potent, hazardous, and controlled substances manufacturing.\r\n Integrated Laboratory Sy...